πŸ‡ΊπŸ‡Έ FDA
Patent

US 11192944

Methods of inducing complement activity

granted A61KA61K2039/505

Quick answer

US patent 11192944 (Methods of inducing complement activity) held by Bioverativ USA Inc. expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Bioverativ USA Inc.
Grant date
Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505